{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:30:06Z","timestamp":1786437006039,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,16]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Pain management in patients with malignant tumors and concomitant bone and soft tissue metastases remains a significant clinical challenge, with 10% to 20% experiencing refractory cancer pain. These patients often present with multiple comorbidities and abnormal biochemical markers, necessitating a multimodal approach to therapy. The personalized application of patient-controlled analgesia (PCA) technology has shown promise in enabling swift and effective pain management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 66 year old male patient with metastatic lower esophageal cardia cancer was hospitalized due to uncontrollable right chest and back pain. Effective control was achieved through multimodal comprehensive treatment, especially the application of PCA technology. At the same time, the patient also received the opportunity of antitumor therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>He was diagnosed with (1) stage IV cardial adenocarcinoma of lower esophagus (rT3N0M1); (2) secondary malignant tumor of bone; (3) refractory cancer pain (numerical rating scale score 6 scores); (4) chronic viral hepatitis B; (5) hepatic insufficiency; (6) incomplete intestinal obstruction; and (7) chronic erosive gastritis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The complete process of cancer pain treatment for a patient with lower esophageal and cardia cancer was analyzed. The titration and rotation of opioid dosage, adjuvant treatment of underlying diseases, prevention and treatment of drug-related adverse reactions were introduced, with emphasis on PCA rapid titration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient\u2019s cancer pain is well controlled, with mild adverse reactions and timely treatment. In addition, the patient also received antitumor treatment (radiotherapy and targeted therapy).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case underscores the importance of comprehensive evaluation and precise diagnosis in cancer pain management, highlighting the need to address underlying conditions, conduct multidisciplinary consultations, and develop personalized analgesia plans. Such approaches can enhance pain treatment efficacy, minimize adverse reactions, and improve the overall quality of life for cancer patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000042433","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T14:00:57Z","timestamp":1747836057000},"page":"e42433","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Analgesic treatment of refractory cancer pain caused by bone and soft tissue metastasis of lower esophageal and cardial adenocarcinoma: A case report"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1638-8986","authenticated-orcid":false,"given":"Jiying","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ding","sequence":"additional","affiliation":[{"name":"Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mincheng","family":"Yu","sequence":"additional","affiliation":[{"name":"Institute of Medicine and Nursing, Hubei University of Medicine, Shiyan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5885-6506","authenticated-orcid":false,"given":"Xiaojun","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260811","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.3390\/curroncol30070500","article-title":"Cancer pain management: a narrative review of current concepts, strategies, and techniques.","volume":"30","author":"Mestdagh","year":"2023","journal-title":"Curr Oncol"},{"key":"R2-20260811","doi-asserted-by":"crossref","first-page":"977","DOI":"10.6004\/jnccn.2019.0038","article-title":"Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology.","volume":"17","author":"Swarm","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"R3-20260811","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/j.pain.0000000000000895","article-title":"Prevalence and incidence of chronic pain with or without neuropathic characteristics in patients with cancer.","volume":"158","author":"Bouhassira","year":"2017","journal-title":"Pain"},{"key":"R4-20260811","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/SPC.0000000000000261","article-title":"Pain prevalence in cancer patients: status quo or opportunities for improvement?","volume":"11","author":"Haumann","year":"2017","journal-title":"Curr Opin Support Palliat Care"},{"key":"R5-20260811","first-page":"1473","article-title":"Pharmacological options for the management of refractory cancer pain\u2014what is the evidence?","volume":"23","author":"Afsharimani","year":"2015","journal-title":"Support Care Cancer"},{"key":"R6-20260811","first-page":"1429","article-title":"Interventional options for the management of refractory cancer pain\u2014what is the evidence?","volume":"24","author":"Vayne-Bossert","year":"2016","journal-title":"Support Care Cancer"},{"key":"R7-20260811","first-page":"787","article-title":"Expert consensus on refractory cancer pain (2017 edition).","volume":"44","author":"Wang","year":"2017","journal-title":"Chin J Clin Oncol"},{"key":"R8-20260811","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jpainsymman.2013.10.018","article-title":"Subcutaneous administration of drugs in palliative care: results of a systematic observational study.","volume":"48","author":"Bartz","year":"2014","journal-title":"J Pain Symptom Manage"},{"key":"R9-20260811","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.6004\/jnccn.2020.7699","article-title":"Comparing patient-controlled analgesia versus non-PCA hydromorphone titration for severe cancer pain: a randomized phase III trial.","volume":"19","author":"Lin","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"key":"R10-20260811","first-page":"182","article-title":"Optimal pain management for patients with cancer in the modern era.","volume":"68","author":"Scarborough","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R11-20260811","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2147\/JPR.S451698","article-title":"Patient-controlled subcutaneous analgesia with hydromorphone versus oral oxycontin for opioid titration of cancer pain: a prospective multicenter randomized trial.","volume":"17","author":"Xiao","year":"2024","journal-title":"J Pain Res"},{"key":"R12-20260811","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.socscimed.2019.05.042","article-title":"The commensuration of pain: How nurses transform subjective experience into objective numbers.","volume":"233","author":"Johannessen","year":"2019","journal-title":"Soc Sci Med"},{"key":"R13-20260811","doi-asserted-by":"crossref","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","article-title":"Management of cancer pain in adult patients: ESMO clinical practice guidelines.","volume":"29","author":"Fallon","year":"2018","journal-title":"Ann oncol"},{"key":"R14-20260811","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2147\/DDDT.S414318","article-title":"Guidelines for rational clinical use of fentanyl transdermal patch.","volume":"18","author":"Fu","year":"2024","journal-title":"Drug Design Develop Ther"},{"key":"R15-20260811","first-page":"1463","article-title":"Guidelines for rational use of fentanyl transdermal patch.","volume":"40","author":"Fu","year":"2021","journal-title":"Med Rev"},{"key":"R16-20260811","first-page":"1401","article-title":"Efficacy and safety of transdermal fentanyl patches for opioid initiation in patients with gastrointestinal obstruction.","volume":"41","author":"Miyoshi","year":"2014","journal-title":"Gan To Kagaku Ryoho"},{"key":"R17-20260811","first-page":"637","article-title":"Consensus of experts on the management of malignant bowel obstruction in patients with advanced cancer.","volume":"29","author":"Yu","year":"2007","journal-title":"Chin J Oncol"},{"key":"R19-20260811","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bjan.2018.08.003","article-title":"Effect of melatonin on the daytime sleepiness side-effect of gabapentin in adults patients with neuropathic pain.","volume":"69","author":"Altiparmak","year":"2019","journal-title":"Rev Bras Anestesiol"},{"key":"R20-20260811","doi-asserted-by":"crossref","first-page":"637","DOI":"10.21037\/tcr-20-2692","article-title":"The efficacy of gabapentin combined with opioids for neuropathic cancer pain: a meta-analysis.","volume":"10","author":"Bao","year":"2021","journal-title":"Transl Cancer Res"},{"key":"R21-20260811","first-page":"91","article-title":"Radiotherapy for bone metastasis after esophageal cancer surgery.","volume":"46","author":"Nakaya","year":"2019","journal-title":"Gan To Kagaku Ryoho"},{"key":"R22-20260811","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.canrad.2021.06.021","article-title":"Bone metastasis: efficacy and technical modalities of classical radiotherapy [M\u00e9tastases osseuses: efficacit\u00e9 et modalit\u00e9s de prescription de la radioth\u00e9rapie classique].","volume":"25","author":"Rapeaud","year":"2021","journal-title":"Cancer Radiother"},{"key":"R23-20260811","doi-asserted-by":"crossref","first-page":"418","DOI":"10.21037\/jgo.2016.11.13","article-title":"Biologic therapy in esophageal and gastric malignancies: current therapies and future directions.","volume":"8","author":"Samson","year":"2017","journal-title":"J Gastrointest Oncol"},{"key":"R24-20260811","first-page":"82","article-title":"Interpretation of refractory cancer pain consensus from the Committee of Rehabilitation and Palliative Care (CRPC) experts in 2017(III): metastatic bone pain.","volume":"14","author":"Yang","year":"2018","journal-title":"Pain Clin J"},{"key":"R25-20260811","first-page":"798","article-title":"Application of hydromorphone intravenous controlled analgesic pump in patients with refractory cancer pain caused by liver malignant tumor with multiple metastases: a case report.","volume":"29","author":"Kaixian","year":"2023","journal-title":"Chin J Pain Med"},{"key":"R26-20260811","doi-asserted-by":"crossref","first-page":"921","DOI":"10.37349\/etat.2024.00255","article-title":"Oligometastatic esophageal cancer cured by systemic therapy combined with radiotherapy to primary tumor and metastasis (metastasis-directed therapy)\u2014small case series.","volume":"5","author":"Hingorani","year":"2024","journal-title":"Explor Target Antitumor Ther"},{"key":"R27-20260811","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.meddos.2020.10.002","article-title":"Reduction of cardiac dose using respiratory-gated MR-linac plans for gastro-esophageal junction cancer.","volume":"46","author":"Lee","year":"2021","journal-title":"Med Dosimetry"},{"key":"R28-20260811","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s00432-013-1531-0","article-title":"A survey of patterns of practice on palliative radiation therapy for bone metastasis in Korea.","volume":"139","author":"Chung","year":"2013","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:00:28Z","timestamp":1786435228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":27,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042433","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]}}}